Jenburkt Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on May 30, 2014, to consider and take on record the audited results for the financial year ended on March 31, 2014 and to recommend Dividend, if any.
The above information is a part of company’s filings submitted to BSE.